Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
about
Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literatureManagement before hepatectomy for hepatocellular carcinoma with cirrhosisTumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCCType I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinomaDevelopment and Validation of a New Prognostic System for Patients with Hepatocellular CarcinomaReporting methods in studies developing prognostic models in cancer: a review.Reporting performance of prognostic models in cancer: a review.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.Staging systems for predicting survival of patients with hepatocellular carcinoma after surgerySignificance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center.Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study.Predicting survival in early hepatocellular carcinomaPreoperative Body Mass Index, Blood Albumin and Triglycerides Predict Survival for Patients with Gastric Cancer.Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.Review of current staging systems for hepatocellular carcinoma.Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma.Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 PatientsA novel scoring system predicts adjuvant chemolipiodolization benefit for hepatocellular carcinoma patients after hepatectomy.Prediction of Early Recurrence of Liver Cancer by a Novel Discrete Bayes Decision Rule for Personalized Medicine.Staging systems: is there a surgical staging and a medical one?: hepatologist's perspective.Hepatocellular carcinoma: MR staging and therapeutic decisions.What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.TNM/Okuda/Barcelona/UNOS/CLIP International Multidisciplinary Classification of Hepatocellular Carcinoma: concepts, perspectives, and radiologic implications.Staging systems of hepatocellular carcinoma: a review of literature.Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.Treatment of intermediate-stage hepatocellular carcinoma.A discussion of serum albumin level in advanced-stage hepatocellular carcinoma: a medical oncologist's perspective.Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.
P2860
Q24601580-5BAFA6A4-4AD3-4604-8F04-2C6FC78E6DF2Q26783874-7BBB8146-3673-414D-ADDC-207E03457969Q27011253-7B50420D-BB87-4CD5-AE31-30FC65321E62Q28080514-F1F53157-2903-4769-9F58-6AB4D54DD3BEQ28551586-E9B343EB-2EC4-488C-A595-5B162197B751Q30494142-C614319D-BE62-4BA0-9E36-49AD7704E607Q33547696-417ADC94-6C9D-4FD2-B75F-3BBD6A250EF0Q33718951-54C88360-99AD-4291-893D-D64158AB44CCQ33845513-9754846E-6AF9-468A-A3BC-F39806964BC6Q33912315-6D3FB390-F81D-43C6-8F73-B1E6F7BE8696Q34284798-F79E5851-1E41-4CD2-9F0B-243BEE559CF1Q34696921-77859A8B-B3A4-4DED-BE76-B2104BD9355FQ34827366-CFC36FF0-02C8-4948-9F38-260587BD206FQ35073362-62A1406A-1A76-4671-B332-394508B9AAADQ35113002-6BEFE11B-290E-4FA0-B2D3-7DC910FECF82Q35289603-24E0B762-F71D-4D03-B950-5B302DA10AC2Q35626764-76BAB0C8-1ECB-41D5-B1D9-DE51CB83ACCCQ35833112-BA3419EE-62A0-4B57-A232-D9CC59045A47Q36001102-5E17D643-5AEB-4A20-BB84-33D59370899BQ36041631-CEAC554E-5E1A-4ABC-B023-56EC584EB4FEQ36053971-A6991168-F232-4B59-AB35-0ACCDAEB8B69Q36102833-828EF257-B3CC-4CF8-8088-1E778383E08CQ36385705-B046F542-B50E-4BCC-AC74-8FB146F1354CQ36816413-3B8D351B-63C2-43C4-AB90-CAABF9EB82F1Q36945069-F2418659-DA93-4D3E-9109-0EFA342B7CB5Q36952452-933F7543-0A9F-4A6C-B3B6-7E176244B773Q37176395-FE7B166E-BB45-4CC9-81E2-17CC27FC8C20Q37295393-22A33F4B-E3F2-4797-B415-77057F8B7760Q37359190-CE831C65-A454-45A6-9008-AD356B7B12CDQ37630367-B5573525-0855-4B78-B5DE-2AC3B6048962Q37863539-D8957F41-93C5-4ABB-A07C-86BE6B12A9E3Q37886890-E1B43F7F-EE81-4865-BC2C-0100C456DBF2Q37952030-9AC1FFE7-ADCD-431D-B226-8F49AFD8595EQ38046452-798BDE8C-562E-4A2B-8115-4A66405F2530Q38201654-4BB9227F-626D-4768-BE6C-7ACB163017B6Q38207014-08168DC8-6EC5-4064-92FE-6C61F9415A40Q38224434-5034962E-28EE-4092-9747-608A308EFA84Q38236876-7AB5716B-5C99-4491-A867-ABA79C2430B8Q38260315-D9624C75-49E0-429F-857E-63308EF7FA8FQ38366588-E35994D4-5168-4FAF-8BFE-78CCC4CD3F63
P2860
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@ast
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@en
type
label
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@ast
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@en
prefLabel
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@ast
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@en
P2093
P2860
P356
P1433
P1476
Proposal of a new prognostic m ...... : an analysis of 403 patients.
@en
P2093
Fujishima T
Hasegawa K
Makuuchi M
Tateishi R
P2860
P304
P356
10.1136/GUT.2003.035055
P407
P577
2005-03-01T00:00:00Z